Cannabis exposure leads to genetic damage and accelerated aging, raising concerns about its transgenerational health effects and public health implications.
Agios’ tebapivat gets FDA orphan drug designation
Agios focuses on developing groundbreaking therapies for patients with rare diseases. Credit: kiehlord/Shutterstock. Agios Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has
September 12, 2024